SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

Alphabets quarterly earnings miss and heavy AI-infrastructure spending have driven a sharp selloff, with traders debating cash-flow pressure and slowing search-ad monetization against strong Cloud growth and Gemini adoption. Some view the reaction as an overreaction and are buying the dip, while others question whether AI investment can generate returns quickly enough.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovances announcement of positive Phase 2 lifileucel results in previously treated metastatic non-small cell lung cancer, with detailed data and a precision-medicine update still to come, is driving attention. Traders are broadly bullish on the potential to extend the therapy beyond melanoma, while some caution that the headline lacks detailed results and could lead to a sell the news reaction.

Alphabet Inc - Ordinary Shares - Class C

Alphabets earnings miss sparked a sharp selloff, with traders focused on heavy AI infrastructure spending, weaker cash flow, and concerns about search growth and AI monetization. Bulls counter that strong Google Cloud growth shows AI demand is materializing and call the decline an overreaction, while bears question whether the spending will generate adequate returns.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Reported talks to acquire Lumentum are driving discussion, with traders weighing the strategic value of securing scarce optical components for AI data centers against the potential financing, debt, and shareholder-dilution risks. No deal is final, and opinions are split on whether the acquisition would strengthen Marvell or burden shareholders.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNows mixed quarterly results and softer Q4 contracted-revenue growth outlook triggered a sharp selloff, despite strong revenue growth and a higher AI target. Traders debate whether the reaction is an overdone reset or a warning about slowing growth, rich expectations, and AI disruption risks for software companies.

Lumentum Holdings, Inc. engages in the provision of optical and photonic products. It operates through the Cloud and Networking, and Industrial Tech segments. The Cloud and Networking segment refers to a portfolio of optical and photonic components, modules, and subsystems. The Industrial Tech segment includes solid-state lasers, kilowatt-class fiber lasers, ultrafast lasers, diode lasers, and gas lasers. The company was founded in 1979 and is headquartered in San Jose, CA.

Lumentum Holdings Inc

LITE is drawing attention over reports that Marvell is in advanced talks to acquire it, a potential deal tied to demand for scarce optical components used in AI data centers. Traders see strategic value in the combination but debate whether Marvell can finance it without substantial dilution or debt; no agreement has been confirmed, and the rumor has fueled volatile trading.

Fortinet, Inc. provides cybersecurity solutions to a variety of businesses, such as enterprises, communication service providers, government organizations, and small to medium-sized businesses. Its product portfolio includes network security, secure access service edge, enterprise networking, security operations, application security, and operational technology. The company was founded by Ken Xie and Michael Xie in November 2000 and is headquartered in Sunnyvale, CA.

Fortinet Inc

Fortinets quarterly results triggered a sharp selloff despite beating headline estimates and raising its overall outlook, as traders focused on slowing product-growth momentum, a lower service-revenue forecast, and gross-margin pressure after a strong run-up in the stock. The community is split between calling the drop an excessive reaction to a solid quarter and arguing that deceleration and high valuation justified the repricing; weakness also spilled into other cybersecurity stocks.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLASs Phase 3 REGAL AML trial reached its prespecified 80th event, triggering final analysis ahead of topline results; the update disclosed no survival findings. Traders are divided after a sharp selloff, with some seeing a sell-the-news reaction and others buying ahead of the binary readout, while some also point to SLS009 as a secondary catalyst.

Intellia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

The FDAs draft guidance proposing a faster route for some patient-specific gene-editing therapies has lifted gene-editing stocks, including NTLA, though the proposal remains open for comment. Traders also focus on Intellias lonvo-z BLA and potential HAE launch, with optimism about its one-time treatment opportunity tempered by concerns about commercialization and financing.

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

Wendys is drawing attention after a Trian-led investor group made a nonbinding offer to take the company private, which the board is evaluating. Many traders call the offer too low and argue for a higher or competing bid, while others question whether a deal will proceed; short-squeeze speculation is also prominent.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


kysport88scom

Kysport88s com